Control clinical trial with rimactane in fresh, untreated cases of pulmonary tuberculosis.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001835:Body Weight; D006801:Humans; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin